Targeting radiation-resistant hypoxic tumour cells through ATR inhibition.
BACKGROUND: Most solid tumours contain regions of sub-optimal oxygen concentration (hypoxia). Hypoxic cancer cells are more resistant to radiotherapy and represent the most aggressive fraction of a tumour. It is therefore essential that strategies continue to be developed to target hypoxic cancer c...
Main Authors: | Pires, I, Olcina, M, Anbalagan, S, Pollard, JR, Reaper, P, Charlton, P, Mckenna, W, Hammond, E |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2012
|
Similar Items
-
Targeting radiation-resistant hypoxic tumour cells through ATR inhibition
by: Pires, I, et al.
Published: (2012) -
ATR targeting by the novel inhibitor VE-822 selectively sensitizes pancreatic cancer cells and tumors to radiation and chemoradiation
by: Fokas, E, et al.
Published: (2013) -
Targeting ATR in vivo using the novel inhibitor VE-822 results in selective sensitization of pancreatic tumors to radiation.
by: Fokas, E, et al.
Published: (2012) -
The novel ATR inhibitor VE-821 increases sensitivity of pancreatic cancer cells to radiation and chemotherapy.
by: Prevo, R, et al.
Published: (2012) -
The novel ATR inhibitor VE-821 selectively sensitizes pancreatic cancer cells to radiation and chemotherapy
by: Fokas, E, et al.
Published: (2012)